You are viewing the site in preview mode
Skip to main content
| |
NFT n = 192
|
IFT n = 130
|
FHT n = 150
|
|---|
|
Age
|
40 ± 13
|
48 ± 13##
|
47 ± 11##
|
|
Sex(male/female)
|
66/126
|
63/67
|
91/59
|
|
BMI
|
24.18 ± 3.68
|
26.07 ± 3.60##
|
28.06 ± 3.85##**
|
|
WC
|
82.43 ± 10.96
|
88.24 ± 11.32##
|
94.71 ± 9.79##**
|
|
FBG
|
5.32 ± 0.56
|
5.72 ± 1.36#
|
6.00 ± 1.29##
|
|
FINS
|
9.56 ± 5.20
|
12.18 ± 6.95#
|
15.95 ± 9.91##*
|
|
HOMA-IR
|
2.29 ± 1.36
|
3.22 ± 2.51##
|
4.33 ± 2.96##*
|
|
TC
|
4.34 ± 0.88
|
4.74 ± 0.95##
|
5.19 ± 1.02##**
|
|
TG
|
0.88 ± 0.26
|
1.28 ± 0.25##
|
2.98 ± 1.62##**
|
|
HDL-C
|
1.34 ± 0.29
|
1.23 ± 0.26##
|
1.14 ± 0.24##*
|
|
LDL-C
|
2.66 ± 0.65
|
3.05 ± 0.69##
|
3.32 ± 0.70##**
|
|
NAFLD
|
24 (12.5%)
|
40 (30.7%) ##
|
91 (60.6%) ##**
|
- Data are mean ± standard deviation, median (interquartile range), or number (percentage)
- Abbreviations: BMI body mass index, WC waist circumference, FBG fasting blood glucose, FINS fasting plasma insulin concentration, HOMA-IR homeostasis model assessment of insulin resistance, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein-cholesterol, LDL-C low-density lipoprotein-cholesterol, NAFLD nonalcoholic fatty liver disease, NFT normal fat tolerance, IFT impaired fat tolerance, FHT fasting hypertriglyceridemia
- # P < 0.05, compared with the NFT group. ## P < 0.01, compared with the NFT group. * P < 0.05, compared with the IFT group. ** P < 0.01, compared with the IFT group
